XML 85 R72.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions - Additional Information (Details)
1 Months Ended 3 Months Ended 6 Months Ended
Oct. 31, 2020
USD ($)
Feb. 29, 2020
shares
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2021
USD ($)
Founder
Jun. 30, 2020
USD ($)
Related Party Transaction [Line Items]            
Number of founder shareholders | Founder         3  
Equity securities recognition amount     $ 25,814,000 $ 517,000 $ 26,852,000 $ 517,000
Founder Shareholders | Scientific Consulting and Other Expenses            
Related Party Transaction [Line Items]            
Payments made to related parties         200,000 100,000
Verve Therapeutics, Inc.            
Related Party Transaction [Line Items]            
Equity securities recognition amount     25,800,000   26,900,000  
Equity securities     $ 29,300,000   29,300,000  
Verve Therapeutics, Inc. | Common Stock            
Related Party Transaction [Line Items]            
Number of shares purchased under equity method | shares   546,970        
Verve Therapeutics, Inc. | Research and Development Expense            
Related Party Transaction [Line Items]            
Purchases from related party         200,000  
Verve Therapeutics, Inc. | Series A Preferred Stock Shares            
Related Party Transaction [Line Items]            
Purchases from related party           $ 800,000
Reimbursed Costs | Prime Agreement | Interest and Other Income (Expense), Net | Prime Medicine Inc            
Related Party Transaction [Line Items]            
Income from related party $ 30,000       $ 100,000